NASDAQ : OPK
OPKO Health, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 1.66 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.24B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.24B |
| Enterprise Value | 1.34B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 746.33M |
| Shares Outstanding | 746.33M |
| Shares Change (YoY) | +12.40% |
| Shares Change (QoQ) | -0.48% |
| Owned by Insiders (%) | 43.22% |
| Owned by Institutions (%) | 25.92% |
| Float | 323.73M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.11 |
| Forward PS | 2.27 |
| PB Ratio | 1.05 |
| P/TBV Ratio | 41.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.35 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.73 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -5.88% |
| Return on Assets (ROA) | -5.52% |
| Return on Invested Capital (ROIC) | -13.16% |
| Return on Capital Employed (ROCE) | -9.99% |
| Weighted Average Cost of Capital (WACC) | 11.65% |
| Revenue Per Employee | $258,416 |
| Profits Per Employee | -$32,040 |
| Employee Count | 2,275 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 7.39 |
Taxes
| Measure | Value |
|---|
| Income Tax | -6.96M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.50 |
| 52-Week Price Change | +16.08% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 1.34 |
| Relative Strength Index (RSI) | 58.85 |
| Average Volume (20 Days) | 5,458,485 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 34.01M |
| Short Previous Month | 35.56M |
| Short % of Shares Out | 4.56% |
| Short % of Float | 10.51% |
| Short Ratio (days to cover) | 7.73 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 587.90M |
| Gross Profit | 114.48M |
| Operating Income | -167.89M |
| Pretax Income | -79.85M |
| Net Income | -72.89M |
| EBITDA | -78.17M |
| EBIT | -167.89M |
| Loss Per Share | -$0.09 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 300.76M |
| Total Debt | 398.08M |
| Net Cash | -97.32M |
| Net Cash Per Share | -$0.13 |
| Equity (Book Value) | 1.18B |
| Book Value Per Share | 1.59 |
| Working Capital | 350.87M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -123.38M |
| Capital Expenditures | -10.64M |
| Depreciation & Amortization | 89.72M |
| Net Borrowing | -5.68M |
| Free Cash Flow | -134.02M |
| FCF Per Share | -$0.18 |
Margins
| Measure | Value |
|---|
| Gross Margin | 19.47% |
| Operating Margin | -28.56% |
| Pretax Margin | -13.58% |
| Profit Margin | -12.40% |
| EBITDA Margin | -13.30% |
| EBIT Margin | -28.56% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -12.40% |
| Shareholder Yield | -12.40% |
| Earnings Yield | -5.63% |
| FCF Yield | -10.82% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $4.15 |
| Price Target Difference | 150.00% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | -0.07% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.6 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |